The efforts of the scientific and medical communities over the past 50 years have brought hope to many patients with ...

Hypertension does not directly cause dyspnoea; however it can lead to long-term effects on the heart and arteries ...

In April 2025, Actelion announced a study is to demonstrate superiority of macitentan 75 milligrams (mg) in prolonging the ...

Analyses from Randomized Controlled Trials Further Support the Target Engagement and Safety Profile of Ampreloxetine in Neurodegenerative Disease< ...

Pulmonary arterial hypertension (PAH) is a rare form of pulmonary hypertension. It occurs because progressive vascular ...